Z
Zai Lab Ltd (ZLAB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
$23.53
+0.06 (+0.26%)
Market Cap: $3.07B
Last updated: Nov 17, 2026 at 4:10 PM ET
Zai Lab Ltd (ZLAB) Valuation Multiples
Zai Lab (ZLAB) trades at 6.0x sales and 4.7x book value. Its P/S of 6.0x is below its 5-year median of 71.1x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | N/A |
| Price to sales | 6.0x |
| Price to book | 4.7x |
| PEG | N/A |
| FCF yield | -7.0% |
Historical Medians
Against its 10-year medians, its P/B is 87.1% below 36.5x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 6.0x | 71.1x | N/A |
| P/B | 4.7x | 25.9x | 36.5x |
Valuation History
Over the 5 of the 9 year ends shown that have a P/S, its P/S ranged from 4.2x in 2025 to 407.9x in 2021. 2025 was the lowest of those years.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $17.64 | 4.2x | 2.7x |
| 2024 | $26.19 | 19.1x | 3.2x |
| 2023 | $27.33 | 99.0x | 33.3x |
| 2022 | $30.70 | 136.8x | 28.2x |
| 2021 | $62.85 | 407.9x | 43.5x |
| 2020 | $135.34 | N/A | 101.3x |
| 2019 | $41.59 | N/A | 95.9x |
| 2018 | $23.22 | N/A | 53.7x |
| 2017 | $21.23 | N/A | 296.8x |
Frequently Asked Questions About ZLAB
What is ZLAB's price to sales ratio?
Zai Lab has a price to sales ratio of 6.0x.
ZLAB pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors